Novavax begins phase one of coronavirus vaccine trial after $388M Gates-backed group funding

Novavax has begun phase one of its clinical trail for a coronavirus vaccine candidate. Yahoo Finance’s Anjalee Khemlani breaks down the latest developments.

from Yahoo Finance https://ift.tt/2ZAvkMh